Dr. Beata Gromadzka is a molecular biologist and research team leader specializing in recombinant vaccine technology, protein engineering, and virus-like particles (VLPs). She graduated from the Intercollegiate Faculty of Biotechnology UG & MUG and defended her Ph.D. in 2023 in the field of life sciences, focusing on the design and application of VLPs to monitor RNA virus infections. Since 2016, she has been the founder and CEO of NanoExpo and has led multiple cutting-edge R&D projects in nanobiotechnology, molecular diagnostics, and environmental biosensing. A laureate of the 6th edition of the LIDER program (NCBR), she is also the founder of Sky Way Biolab and Hybridovax. Dr. Gromadzka holds over 35 patents and patent applications, is the author of numerous scientific publications, and a frequent international speaker. In 2020, she established the Department of In Vitro Studies at the Institute of Biotechnology and Molecular Medicine. As an interdisciplinary expert, she contributes to key research consortia (PeptAIm, GlassPoPep, ASTACUS), integrating bioinformatics, biotechnology, and advanced materials. With over 20 years of experience as a biotech entrepreneur and a background in gastronomy, she is committed to translating scientific innovation into real-world medical and health applications.